We are analyzing https://link.springer.com/article/10.1007/s11596-013-1190-z.

Title:
Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson’s disease | Current Medical Science
Description:
The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilson’s disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Health & Fitness
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, disease, wilsons, treatment, patients, dmps, google, scholar, penicillamine, pubmed, efficacy, cross, combination, intravenous, adverse, effects, access, cas, privacy, cookies, content, journal, chelation, repeatedly, pca, oral, zinc, therapy, information, publish, search, huazhong, medical, clinical, safety, sodium, drug, neurol, sci, data, log, research, university, science, technology, zhu, ling, chen, copper, open,

Topics {✒️}

3-dimercapto-1-propane sulfonate month download article/chapter short-term intravenous dmps zinc versus d-penicillamine authors contributed equally full article pdf privacy choices/manage cookies maitain lifelong therapy initial penicillamine therapy related subjects tongji medical college xu-fang li european economic area poor curative effect susceptibility-weighted imaging expert opin pharmacother rare genetic disorder decompensated liver cirrhosis clin pharm ther article xu conditions privacy policy urine copper excretion urine copper tended combined chelation regimen hui-yun zhu accepting optional cookies administrated intravenous dmps adverse effects recovered liver function alleviated neurologic symptoms intravenous dmps alternately combined sodium dimercaptopropanesulfonate alternative orphan medicines key words wilson journal finder publish article journal oral pca alternately check access instant access clinical efficacy article log symptomatic wilson disease author correspondence oral pca treatment article cite line therapy anticopper efficacy chelation treatment repeatedly d-penicillamine medical center

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson’s disease
         description:The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilson’s disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
         datePublished:2013-10-20T00:00:00Z
         dateModified:2013-10-20T00:00:00Z
         pageStart:743
         pageEnd:747
         sameAs:https://doi.org/10.1007/s11596-013-1190-z
         keywords:
            Wilson’s disease
            sodium 2, 3-dimercapto-1-propane sulfonate
            penicillamine
            efficacy
            adverse effects
            Medicine/Public Health
            general
         image:
         isPartOf:
            name:Journal of Huazhong University of Science and Technology [Medical Sciences]
            issn:
               1993-1352
               1672-0733
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:San-qing Xu
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xu-fang Li
               affiliation:
                     name:Guangzhou Women and Children’s Medical Center
                     address:
                        name:Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hui-yun Zhu
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yan Liu
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Fang
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ling Chen
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson’s disease
      description:The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilson’s disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
      datePublished:2013-10-20T00:00:00Z
      dateModified:2013-10-20T00:00:00Z
      pageStart:743
      pageEnd:747
      sameAs:https://doi.org/10.1007/s11596-013-1190-z
      keywords:
         Wilson’s disease
         sodium 2, 3-dimercapto-1-propane sulfonate
         penicillamine
         efficacy
         adverse effects
         Medicine/Public Health
         general
      image:
      isPartOf:
         name:Journal of Huazhong University of Science and Technology [Medical Sciences]
         issn:
            1993-1352
            1672-0733
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:San-qing Xu
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xu-fang Li
            affiliation:
                  name:Guangzhou Women and Children’s Medical Center
                  address:
                     name:Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hui-yun Zhu
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yan Liu
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Fang
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ling Chen
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Huazhong University of Science and Technology [Medical Sciences]
      issn:
         1993-1352
         1672-0733
      volumeNumber:33
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Huazhong University of Science and Technology
      address:
         name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Guangzhou Women and Children’s Medical Center
      address:
         name:Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:San-qing Xu
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Xu-fang Li
      affiliation:
            name:Guangzhou Women and Children’s Medical Center
            address:
               name:Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Hui-yun Zhu
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Yan Liu
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Feng Fang
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Ling Chen
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou, China
      name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(60)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.94s.

LINK . SPRINGER . COM {}